Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1007/s11136-015-1185-2) contains supplementary material, which is available to authorized users.
Taste and smell alterations (TSAs) are among the most frequent and troublesome symptoms reported by head and neck cancer (HNC) patients after treatment. Little is known about the relationship between TSAs and quality of life (QoL) among HNC patients. The aim of this study was to determine the effect of TSAs on overall QoL among tube-fed and orally fed HNC patients before treatment, at end of treatment and at 2.5-month follow-up.
Data were collected in a longitudinal study prior to treatment (n = 126), at end of treatment (n = 100) and at 2.5-month follow-up (n = 85). Chemosensory Complaint Score (CCS) and the University of Washington Quality of Life Questionnaire version 3 were used to assess TSAs and QoL, respectively. Generalized estimated equation modeling was used to estimate the effect of CCS on QoL.
At end of treatment, QoL and CCS had declined for both tube-fed and orally fed patients and thereafter improved, but not to pre-treatment levels. Neither QoL nor CCS mean scores were different between the two groups at any time point. CCS was a significant predictor of overall QoL (β = −1.82, p < 0.0001), social-emotional (β = −1.76, p < 0.0001), physical (β = −1.12, p < 0.0001) and overall functions (β = −1.15, p < 0.0001) at a multivariate level. Taste was reported as an important symptom for both tube-fed and orally fed groups at end of treatment and follow-up.
TSAs are an important symptom and an independent predictor of QoL for both tube-fed and orally fed HNC patients. HNC patients need support to manage TSAs, regardless of the method of nutritional intake.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Supplementary material 1 (DOCX 26 kb)11136_2015_1185_MOESM1_ESM.docx
Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Baracos, V. E., & Wismer, W. V. (2011). Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. Journal of Pain and Symptom Management, 41(4), 673–683. CrossRefPubMed
Hong, J. H., Omur-Ozbek, P., Stanek, B. T., Dietrich, A. M., Duncan, S. E., Lee, Y. W., & Lesser, G. (2009). Taste and odor abnormalities in cancer patients. The Journal of Supportive Oncology, 7(2), 58–65. PubMed
Nugent, B., Lewis, S., & O’Sullivan, J. M. (2013). Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database of Systematic Reviews, 1, 007904.
Redda, M. G. R., & Allis, S. (2006). Radiotherapy-induced taste impairment. Cancer Treatment Reviews, 32, 541–547. CrossRef
Fang, F. M., Chien, C. Y., Tsai, W. L., Chen, H. C., Hsu, H. C., Lui, C. C., et al. (2008). Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—A longitudinal study. International Journal of Radiation Oncology Biology Physics, 72(2), 356–364. CrossRef
List, M., Stracks, J., Colangelo, L., Butler, P., Ganzenko, N., Lundy, D., et al. (2000). How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? Journal of Clinical Oncology, 18(4), 877–884. PubMed
Friedman, M. L. (1997). Basic issues and challenges. In Improving the quality of life: A holistic scientific strategy (pp. 4–17). Westport, CT: Praeger Publishers.
Gibson, R. S. (1990). Principles of nutritional assessment. Oxford, UK: Oxford University Press.
Bruera, E., Chadwick, S., Cowan, L., Drebit, D., Hanson, J., MacDonald, N., et al. (1986). Caloric intake assessment in advanced cancer patients: comparison of three methods. Cancer Treatment Reports, 70(8), 981–983. PubMed
Rogers, S. N., & Lowe, D. (2010). The University of Washington Quality of Life Scale. In V. R. Preedy & R. R. Watson (Eds.), Handbook of disease burdens and quality of life measures (p. 101). New York, USA: Springer Science+Business MEDIA LLC. CrossRef
Diggle, P., Heagerty, P., Liang, K., & Zeger, S. (2002). Analysis of longitudinal data (2nd ed.). Oxford: Oxford University Press.
Liang, K., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73(1), 13–22. CrossRef
Chera, B. S., Eisbruch, A., Murphy, B. A., Ridge, J. A., Gavin, P., Reeve, B. B., et al. (2014). Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. Journal of the National Cancer Institute, 106(7), JU127. CrossRef
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014). Cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 9–29.
Canadian Cancer Society’s Advisory Committee on Cancer Statistics. (2014). Canadian cancer statistics 2014. Toronto, ON: Canadian Cancer Society.
Wickham, R. S., Rehwaldt, M., Kefer, C., Shott, S., Abbas, K., Glynn-Tucker, E., et al. (1999). Taste changes experienced by patients receiving chemotherapy. Oncology Nursing Forum, 26(4), 697–706. PubMed
- The impact of taste and smell alterations on quality of life in head and neck cancer patients
R. A. Scrimger
K. P. Chu
W. V. Wismer
- Springer International Publishing